T-3262 IN OBSTETRICS AND GYNECOLOGY
スポンサーリンク
概要
- 論文の詳細を見る
We investigated a newly developed antimicrobial agent T-3262, which is a pyhridone-carboxylic derivative, for its clinical efficacy in obstetric and gynecological infections.<BR>T-3262 was administered to 11 patients with intrauterine infection (4 patients), uterine adnexitis (3), infection of external genitalia (2) and colpo-infection (2).<BR>The daily dose of T-3262 was 300 mg in 1 case and 450 mg in 10 cases. The duration of administration was 7-14 days.<BR>The clinical effect was excellent in 1 case and good in 10 cases, and the efficacy rate was 1005.<BR>Neither subjective and objective side effects nor abnormal laboratory findings were observed.<BR>This drug is expected to be very useful against infections treated orally by drugs in obstetrics and gynecology.
- 公益社団法人 日本化学療法学会の論文
公益社団法人 日本化学療法学会 | 論文
- DISPOSITION OF 7432-8 IN RATS (I)
- CLINICAL STUDIES ON T-1220 IN SURGICAL CASES
- CLINICAL STUDIES OF PIVALOYLOXYMETHYL D-α-AMINOBENZYL-PENICILLINATE HYDROCHLORIDE IN SURGICAL INFECTIONS
- STUDIES ON AC-1370
- Primary treatment with a combination of cyclophosphamide, vincristine, and dacarbazine for recurrent malignant pheochromocytoma: A case report.